Validation of Caratol E Tablet for its Melanogenesis Effect—In Vitro Study

Authors

  • G.V. Amrutha Valli

Abstract

Vitiligo is a skin disorder characterized by pale patches due to lack of melanin. Lack of melanin may be due to reduced melanogenesis, lack of melanocytes and decreased tyrosinase activity. In the present study, Caratol E tablet was evaluated for its melanogenesis effect. Melanocytes viability was evaluated by MTT assay and tyrosinase assay. Caratol E tablet showed positive effect in increasing the melanogenesis. Results are discussed in the present paper.

 

Keywords: Caratol E tablet, melanogenesis, tyrosinase assay

Cite this Article

Amruthavalli GV, Aruna V, Gayathri R. Validation of Caratol E Tablet for its Melanogenesis Effect—in vitro Study. Research & Reviews: A Journal of Pharmacology. 2018; 8(3): 35–37p.

Downloads

Published

2019-01-02

Issue

Vol. 8 No. 3 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.